Pancreatic Cancer Research

ResearcherJohns Hopkins UniversityActive in the last 2 years

Barbara Stauch Slusher

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9814-4157; OpenAlex author ID A5023686004; NIH RePORTER profile ID 10442611. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
1
Labs led
1
Collaborators
10
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 grant · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. CRISPR screen of human pancreatic cancer xenografts identifies a KLF5 proliferation vulnerability through epigenetic modifiers NCAPD2 and MTHFD1. Co-author DOI 10.1186/s12943-026-02575-z↗
  2. Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer. Co-author DOI 10.1002/pmic.201800451↗
  3. Combination therapy with BPTES nanoparticles and metformin targets the metabolic heterogeneity of pancreatic cancer. Co-author DOI 10.1073/pnas.1611406113↗

Grants 1

  1. Glutaminase Inhibitor Drug Discovery and Nanoparticle-Based Delivery for Pancreatic Cancer Therapy R01CA193895↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Anne Le · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
  2. Justin S. Hanes · 2 shared papers, 1 shared grant, 2016–2020 · strength 0.49
  3. Andrew P. Feinberg · 1 shared paper, 2026 · strength 0.24
  4. Masahiro Maeda · 1 shared paper, 2026 · strength 0.24
  5. Jimin Min · 1 shared paper, 2026 · strength 0.24
  6. Anirban Maitra · 1 shared paper, 2026 · strength 0.24
  7. Amira Elgogary · 2 shared papers, 2016–2019 · strength 0.12
  8. Jie Fu · 2 shared papers, 2016–2019 · strength 0.12
  9. Sunag Udupa · 1 shared paper, 2019 · strength 0.07
  10. Sarah Zimmermann · 1 shared paper, 2016 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.